Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2026 on Thursday, January 29, 2026, after the New York Stock ...
San Diego-based ResMed, a maker of products for treating sleep disorder, marked 25 years in business Monday by revamping its website and introducing a new company logo with the tagline, “Changing ...
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update. ResMed Inc. has filed a Form SD for the 2023 reporting period, detailing their compliance with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback